| abstract |
It is intended to provide a molecule which is present on the Rb pathway and can be used as a drug discovery target for an anticancer agent or a tumor marker and a method capable of evaluating a compound (a candidate compound for an anticancer agent) using the molecule. The object can be achieved by a method for evaluating a compound which detects the interaction between IL-8, IL-8 receptor, ECT2, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, CCNE2, FEN1, HMGB2, CENPE, KIF20A, CDC25C, CDCA8, KIF11, HCAP-E, HCAP-G, KNTC2, HCAP-C, BUB1, NEK2, CCNA2 or KIF18A gene or protein and a test compound. |